Drug discovery team
Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets.
Our Drug Discovery Institute couples the biological expertise of international collaborators with innovative in-house drug discovery expertise. Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets. We then establish assays to screen compound libraries for hits against these targets and improve hits into potent and selective lead compounds. This provides the basis for the development of the next generation of medicines to treat neurodegeneration.
| Biology | |
|---|---|
| Core Disciplines: | Neurobiology, Pharmacology, Screening |
| Head of Biology: | Paul Whiting (interim) |
| Scientists: | Sarah Jolly Lorenza Magno Emma Armstrong Fiona Jeganathan Kathryn Costelloe Dawn Lau Leela Phadke Stefano Benvegnu Susannah Baird Chandni Patel Lucy Granat Carmen Navarron Satinder Samra Audrey Colomba Daniel Bull (PhD student) |
| Chemistry | |
|---|---|
| Core Disciplines: | Medicinal & synthetic chemistry, Chemical biology, Computational chemistry |
| Head of Chemistry: | Paul Fish |
| Scientists: | Fredrik Svensson |